These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24809802)

  • 21. Polyphosphate amplifies proinflammatory responses of nuclear proteins through interaction with receptor for advanced glycation end products and P2Y1 purinergic receptor.
    Dinarvand P; Hassanian SM; Qureshi SH; Manithody C; Eissenberg JC; Yang L; Rezaie AR
    Blood; 2014 Feb; 123(6):935-45. PubMed ID: 24255918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
    Tang Z; Zang N; Fu Y; Ye Z; Chen S; Mo S; Ren L; Liu E
    Biochem Biophys Res Commun; 2018 Jun; 501(1):1-8. PubMed ID: 29571731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
    Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
    J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities.
    Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting.
    Paudel YN; Angelopoulou E; Piperi C; Othman I; Aamir K; Shaikh MF
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
    Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
    Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
    Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
    Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
    Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation.
    Wan W; Cao L; Khanabdali R; Kalionis B; Tai X; Xia S
    J Immunol Res; 2016; 2016():6430423. PubMed ID: 27294160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
    Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
    Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
    Sachdev U; Cui X; Tzeng E
    J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
    Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
    Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurogenesis after traumatic brain injury - The complex role of HMGB1 and neuroinflammation.
    Manivannan S; Marei O; Elalfy O; Zaben M
    Neuropharmacology; 2021 Feb; 183():108400. PubMed ID: 33189765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
    Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE
    Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
    Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
    Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
    Urbonaviciute V; Fürnrohr BG; Meister S; Munoz L; Heyder P; De Marchis F; Bianchi ME; Kirschning C; Wagner H; Manfredi AA; Kalden JR; Schett G; Rovere-Querini P; Herrmann M; Voll RE
    J Exp Med; 2008 Dec; 205(13):3007-18. PubMed ID: 19064698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury.
    Qing X; Pitashny M; Thomas DB; Barrat FJ; Hogarth MP; Putterman C
    Immunol Lett; 2008 Nov; 121(1):61-73. PubMed ID: 18822317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways.
    He ZW; Qin YH; Wang ZW; Chen Y; Shen Q; Dai SM
    Mediators Inflamm; 2013; 2013():596716. PubMed ID: 24302816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High mobility group box-1 (HMGB1) antagonist BoxA suppresses status epilepticus-induced neuroinflammatory responses associated with Toll-like receptor 2/4 down-regulation in rats.
    Yu S; Zhang H; Hei Y; Yi X; Baskys A; Liu W; Long Q
    Brain Res; 2019 Aug; 1717():44-51. PubMed ID: 30986405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.